HighTower Advisors, LLC
- SEC CIK
- 0001462245
- Latest filing
- Aug 25, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −20,700−100.0% | Sold out | Holders |
| Q1 2025 | 20,700 | $138.1K | <0.1% | +2,952+16.6% | Added | Holders |
| Q4 2024 | 17,748 | $223.1K | <0.1% | −1,073−5.7% | Reduced | Holders |
| Q3 2024 | 18,821 | $346.0K | <0.1% | −5,556−22.8% | Reduced | Holders |
| Q2 2024 | 24,377 | $525.0K | <0.1% | +165+0.7% | Added | Holders |
| Q1 2024 | 24,212 | $653.0K | <0.1% | −3,504−12.6% | Reduced | Holders |
| Q4 2023 | 27,716 | $831.0K | <0.1% | −1,000−3.5% | Reduced | Holders |
| Q3 2023 | 28,716 | $589.0K | <0.1% | −1,613−5.3% | Reduced | Holders |
| Q2 2023 | 30,329 | $603.0K | <0.1% | −117,400−79.5% | Reduced | Holders |
| Q1 2023 | 147,729 | $2.53M | <0.1% | +55,175+59.6% | Added | Holders |
| Q4 2022 | 92,554 | $1.81M | <0.1% | +65,107+237.2% | Added | Holders |
| Q3 2022 | 27,447 | $439.0K | <0.1% | −2,653−8.8% | Reduced | Holders |
| Q2 2022 | 30,100 | $416.0K | <0.1% | +9,100+43.3% | Added | Holders |
| Q1 2022 | 21,000 | $336.0K | <0.1% | +4,879+30.3% | Added | Holders |
| Q4 2021 | 16,121 | $351.0K | <0.1% | +761+5.0% | Added | Holders |
| Q3 2021 | 15,360 | $460.0K | <0.1% | −800−5.0% | Reduced | Holders |
| Q2 2021 | 16,160 | $716.0K | <0.1% | −790−4.7% | Reduced | Holders |
| Q1 2021 | 16,950 | $750.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.